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ABSTRACT
Protein tyrosine phosphatases (PTPs) are important regulators of various cellular 
processes such as proliferation, metabolism, differentiation, and apoptosis. 
Intriguingly, there are members that display the structural features of PTP 
enzymes, but lack the critical nucleophilic cysteine in the active site for catalysis. 
Thus, these proteins are catalytically dead and referred to as 
pseudophosphatases. However, they maintain their ability to bind 
phosphorylated residues, thus, serving as substrate “traps”. This substrate “trap” 
ability is useful in understanding the functions of pseudophosphatases. A 
member of the dual specificity phosphatase subfamily of PTPs, MK-STYX 
(MAPK (mitogen-activated protein kinase)
phospho-serine/threonine/tyrosine-binding protein) is a pseudophosphatase. 
MK-STYX is catalytically inactive due to the fact that it has a phenylalanine and 
serine in its signature motif instead of the expected histidine and cysteine. Our 
previous work utilized the substrate-trap ability and mass spectrometry for 
functional characterization of MK-STYX, which implicated MK-STYX in the stress 
response pathway. MK-STYX binds G3BP1 (GTPase activating protein (SH3 
domain) binding protein 1), causing a decrease in the presence of stress 
granules. However, MK-STYX remains relatively uncharacterized. To further 
characterize MK-STYX’s function, its role in heat shock protein 70 (hsp70) 
signaling was investigated. Hsp70 was previously identified as a potential 
binding partner of MK-STYX using mass spectrometry experiments. Both 
MK-STYX and hsp70 have a similar function, as both proteins are capable of 
decreasing the presence of stress granules. In studying this interaction, hsp70 
expression or the phosphorylation of heat shock transcription factor-1 (hsf-1) 
was not affected by MK-STYX. However, we have found that MK-STYX is a 
promising binding partner of hsp70. Considering the interaction between G3BP1 
and MK-STYX led to understanding the pseudoposphatase’s role in the stress 
response pathway, further characterization of MK-STYX’s function via G3BP1’s 
was pursued. G3BP1 has been implicated in neuronal development. Additionally, 
over-expression of MK-STYX is known to induce neurite formation in PC12 cells. 
Here, by knocking-down MK-STYX with a short-hairpin RNA expression plasmid, 
we have found that the pseudophosphatase is an important regulator of neurite 
outgrowth. Overall, this project provides more insight into MK-STYX by further 
characterizing this protein’s interaction partners and cellular role.
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General Introduction
In order to survive, cells must carry out important cellular processes, such 
as communication and growth. These processes require the relay of extracellular 
signals to the interior of the cell to elicit the proper response. For example, 
neighboring cells interact through cell-surface receptors, and ligands may signal 
for growth. These signals are then transmitted through protein signaling 
cascades. Proteins can have a variety of cellular functions, such as acting as 
enzymes, receptors, or scaffolds. Regardless of their role, many proteins are 
regulated via post-translation modifications. These changes occur after a protein 
has been synthesized, hence post-translationally. In this process, a protein 
becomes tagged with another functional group or molecule. These additions can 
affect the localization, activity, and degradation of the protein, and thereby control 
cellular activity. Post-translational modifications can be either reversible, such as 
phosphorylation and ubiquitination, or irreversible such as proteolysis. Of the 
various post-translational modifications characterized, phosphorylation is the 
most common (Khoury et al., 2011; Walsh, 2006).
Phosphorylation is regulated by kinases which add phosphate groups, and 
phosphatases which remove them. As proteins become phosphorylated, a 
phosphate group (P043') is most commonly added to serine (Ser), threonine 
(Thr), or tyrosine (Tyr) residues. Once added, the phosphate group gives a 
protein the capacity to form new electrostatic interactions and hydrogen bonds
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(Johnson and Lewis, 2001). The new interactions can cause dramatic 
conformational changes, which in turn help regulate a protein’s function.
Protein phosphorylation
With about a third of mammalian proteins being regulated through 
phosphorylation, the balance between protein phosphorylation and 
dephosphorylation is an integral part of maintaining cellular homeostasis (Cohen, 
1999). While phospho-Ser and phosphor-Thr residues are much more common 
in the cell than phosphor-Tyr (1800:200:1, respectively), 107 of the approximately 
150 phosphatases are protein tyrosine phosphatases (Mann et al., 2002;
Jackson and Denu, 2001; Alonso et al., 2004). The fact that over 70% of 
phosphatases are dedicated to dephosphorylating a small proportion of residues 
indicates that the reversible regulation of tyrosine phosphorylation is crucial for 
the cell.
Protein tyrosine phosphatases
The protein tyrosine phosphatase (PTP) superfamily encodes the largest 
group of phosphatases and is characterized by the active site signature motif 
HCX5R (H: histidine, C: cysteine, X: any amino acid, R: arginine) (Tonks, 2006; 
Jeffrey et al., 2007). This superfamily consists of roughly 107 members and can 
be broken down into classes and subgroups based on flanking domains, 
substrate specificity and homology (Figure 1) (Alonso et al., 2004; Tonks, 2013). 
Although there are low sequence similarities between classes, all PTP members
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maintain a similar catalytic fold and active site architecture (Stone and Dixon, 
1994; Huang, 2003).
The dephosphorylation reaction catalyzed by protein tyrosine 
phosphatases is reliant on the active site cysteine and arginine residues. The 
cysteine residue is essential for catalysis, and is responsible for nucleophilic 
attack on the phosphate. The positively charged arginine residue facilitates this 
reaction by stabilizing the deprotonated cysteine at a neutral pH.
Class II 
(LMPTP)
Class I 
(Cys-based)
Class III 
(Cdc25)
Dual specificity 
phosphatases
Classical” pTyr 
specific PTPs
Protein tyrosine phosphatase superfamily
Figure 1: The protein tyrosine phosphatase superfamily. PTPs can be broken 
into three classes (blue boxes) based on substrate specificity and catalytic 
mechanism. Class I PTPs can be further divided into the classical PTPs, which only 
dephosphorylate phospho-Tyr residues, and the dual specificity phosphatases 
(DUSPs), which can dephosphorylate Ser/Thr, and Tyr residues (red boxes). Class 
II is comprised of the low molecular weight PTP, LMPTP. The Class III PTPs are 
comprised of the cell division cycle 25 (cdc25) phosphatases.
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Dual specificity phosphatases
Dual specificity phosphatases (DUSPs) are members of the PTP 
superfamily which target phosphorylated tyrosine residues, as well as 
phosphorylated serine and threonine residues. In comparison to phospho-Tyr 
specific PTPs, these enzymes have shallower active sites which can 
accommodate both tyrosine and the shorter side chains of serine and threonine 
(Denu and Dixon, 1998; Barford et al., 1998).
The mitogen-activated protein kinase phosphatases (MKPs) are a DUSP 
subgroup (Table 1). MKPs target and dephosphorylate the mitogen-activated 
protein kinases (MAPKs) that have been dual-phosphorylated by MAPKKs, such 
as MEK. The MAPK group encompasses ERKs (extracellular signal-regulated 
kinases), JNKs (c-Jun N-terminal kinases), and p38s (p38 mitogen-activated 
protein kinases). These individual MAPK proteins interact with a vast number of 
downstream targets; the ERKs alone have at least 160 identified substrates. 
Thus, MAPKs can influence a variety of cellular pathways and outcomes (Yoon 
and Seger, 2006). Additionally, most cell surface receptors use at least one 
MAPK to transduce cellular signals (Robinson and Cobb, 1997). Without the 
MKPs to regulate these kinases, processes like cell growth can become 
unregulated and lead to cancer (Boutros et al., 2008).
The N-terminal region of MKPs is responsible for recognizing and 
interacting with MAPKs. This region contains a KIM (kinase-interacting motif) 
between two CH2 (cdc25 homology) domains and is thought to provide the
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different MKPs with their specificity for the various MAPKs (Patterson et al., 
2009). The C-terminal region of MKPs contains the PTP catalytic domain.
Of the eleven MKPs, ten are catalytically active, and one, MK-STYX 
(MAPK (mitogen-activated protein kinase) phospho-serine/threonine/tyrosine- 
binding protein), is catalytically inactive. MK-STYX contains a STYX domain, 
where catalytically essential residues are not present within the active site 
signature motif (Wishart and Dixon, 1998). MK-STYX was classified as a 
member of the MKP subgroup based on its similar domain and sequence 
homology.
Table 1: The mitogen-activated protein kinases phosphatase 
(MKP) subgroup. This PTP subgroup is composed of 10 
catalytically active dual specificity phosphatases, and 1 
catalytically inactive phosphatase, MK-STYX.
Gene MKP
DUSP1 MKP-1
DUSP4 MKP-2
DUSP2 N/A
DUSP5 N/A
DUSP6 MKP-3
DUSP7 MKP-X
DUSP9 MKP-4
DUSP8 N/A
DUSP10 MKP-5
DUSP16 MKP-7
DUSP24 MK-STYX
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Pseudophosphatases
Pseudophosphatases are proteins which lack essential amino acids 
needed for catalysis, rendering them catalytically inactive. Approximately 16% of 
proteins in the PTP superfamily lack the essential catalytic cysteine residue 
found in the HCX5R signature motif (Wishart, 2007). Without this amino acid, 
pseudophosphatases do not have the ability to remove phosphate groups. The 
domain architecture of these catalytically dead enzymes is very similar to that of 
the catalytically active PTPs. Point mutations replacing the catalytic cysteine 
restore enzymatic activity, showing pseudophosphatases still maintain the overall 
active site fold to accommodate dephosphorylation reactions (Wishart et al.,
1995; Hinton et al., 2010).
These catalytically dead enzymes were previously thought to act solely as 
dominant negatives, where they bind and protect a phosphorylated protein from 
being dephosphorylated by active phosphatases. However, it is now known that 
pseudophosphatases can have other functions in the cell, besides merely 
protecting phosphorylated residues.
The MTM family is composed of 14 proteins, 6 of which are catalytically 
inactive and lack the essential cysteine residue within the PTP catalytic motif 
(Laporte et al., 2003). This family of PTPs dispels the notion that 
pseudophosphatases act solely as dominant negatives. It has been shown that 
heterodimers form between the coiled-coil domains of the active and inactive 
MTMs (Kim et al., 2003). The inactive partner relocates and increases the activity 
of the catalytic MTM. In Charcot-Marie-Tooth disease type 4B (CMT4B), loss of
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either the active or the inactive member of the MTM heterodimer are associated 
with this neuropathic disorder (Bolino et al., 2000; Senderek et al., 2003).
Besides MTMs, other pseudophosphatases in the PTP superfamily have 
bona fide regulatory roles, such as the EGG-4 pseudophosphatase in C. 
elegans. EGG-4 interferes with MBK-2 (minibrain kinase 2), which is in the same 
dual-specificity tyrosine-regulated kinase (DYRK) family as the MAPKs. MBK-2 
becomes active following the phosphorylation of the two tyrosine residues found 
in the YXY motif of the activation loop, similar to the TXY motif present in the 
MAPKs. As a pseudophosphatase, EGG-4 functions by binding the tyrosine 
residues found in the YXY motif, altering the substrate binding abilities of MBK-2. 
Interestingly, EGG-4 can associate with MBK-2 when the tyrosine residues in the 
YXY motif are not phosphorylated (Cheng et al., 2009). This supports the notion 
that pseudophosphatases have roles in the cell other than acting as dominant 
negatives protecting phosphorylated residues from dephosphorylation.
MK-STYX
MK-STYX lacks the essential cysteine and histidine amino acids within the 
PTP active site signature motif, rendering it a catalytically inactive phosphatase. 
However, replacing the ‘FS’ sequence to ‘HC’ through site-directed mutagenesis 
generates an active mutant form of MK-STYX by restoring the PTP motif (Hinton 
et al., 2010).
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Role of MK-STYX in disease
MK-STYX is over-expressed in Ewing’s sarcoma family tumors (ESFT) 
due to a transcription factor gene fusion (Siligan et al., 2005). In 85% of ESFTs, a 
chromosomal translocation between chromosomes 11 and 22 creates a fusion 
EWS-FLI1 gene, resulting in a misregulated transcription factor (Siligan et al., 
2005; Delattre et al., 1994). The resulting chimeric protein directly promotes the 
expression of MK-STYX, causing MK-STYX to be consistently over-expressed in 
tumors with the EWS-FLI1 fusion gene. Furthermore, EWS cells show decreased 
survival when MK-STYX is knocked-down (Arora et al., 2010).
While over-expression of MK-STYX has been linked to cancer, its under­
expression can also negatively affect cells. We have found that a modified U20S 
cell line (RDG3) derived from an osteosarcoma tumor has no detectable level of 
MK-STYX protein (Figure 2). Other reports have shown that knockdown of MK- 
STYX in FleLa cells show almost complete resistance to pro-apoptotic 
chemotherapeutics agents, indicating that the loss of MK-STYX can promote 
cancer cell survival (Niemi et al., 2011).
NT M
STYXL1 |
Flag 
(3-tubulin
Figure 2: MK-STYX protein undetectable in RDG3 cells. Cells were either not 
transfected (NT) or received a MK-STYX (M) or pMT2 (P) plasmid. Antibody for 
endogenous MK-STYX (Sigma) only detected protein in sample transfected with the 
flag-tagged MK-STYX plasmid. This shows that without transfection, there is no 
detectable MK-STYX protein in RDG3 cells. (3-tubulin served as a loading control.
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Cellular functions of MK-STYX
Although MK-STYX was first identified and described in 1998, there was 
little information about the cellular role of this protein until 2010 (Wishart and 
Dixon, 1998; Hinton et al., 2010). MK-STYX has the ability to form protein:protein 
interactions via its inactive PTP catalytic domain and CH2 domains. Thus, 
understanding its protein interactions provided insight into the function of MK- 
STYX.
Previously, mass spectrometry was used to identify potential binding 
partners of MK-STYX and the active mutant, F1 (Hinton et al., 2010). These 
experiments ranked the potential binding partners using expectation values (e- 
values). The e-value is a measure of statistical confidence, with a lower value 
corresponds to a more reliable reading. From the resulting readings, proteins 
which gave a lower e-value for MK-STYX over F1 were selected. This could 
indicate that the peptide was a potential binding partner for only the 
pseudophosphatase. Additionally, the preferential binding of MK-STYX over F1 
could show that the pseudophosphatase has its own set of unique interaction 
partners separate from the active mutant phosphatase, implicating very specific 
roles for MK-STYX.
Using this approach, G3BP1 (GTPase activating protein (SH3 domain) 
binding protein 1) was identified as a binding partner of MK-STYX (Hinton et al., 
2010; Barr et al., 2013). G3BP1 is a marker of stress granules (SGs), which are 
cytoplasmic mRNA-containing complexes that form upon cellular stress. These 
granules are composed of stalled pre-initiation complexes where translation has
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halted. Other mRNA binding proteins, such as TIA-1 (TIA1 cytotoxic granule- 
associated RNA binding protein), contain RNA recognition motifs (RRM) which 
allow them to recognize and bind the untranslated mRNA. Another important 
domain present in these proteins is the prion-related domain (PRD) which 
promotes their self-aggregation and formation of SGs.
Previously, it was shown that MK-STYX reduces the presence of SGs 
(Hinton et al., 2010; Barr et al., 2013). Notably, another protein identified in the 
mass spectrometry data, heat shock protein 70 (hsp70), shares this role, and 
was therefore studied as a possible binding partner of MK-STYX (Table 2) (Gilks 
et al., 2004; Kedersha and Anderson, 2002).
Table 2: Potential binding partners of MK-STYX. Mass spectrometry was used to 
identify peptides which were immunoprecipitated with MK-STYX, and its active form, 
F1. The lower expectation value (e-value) seen in the MK-STYX column versus those 
for F1 suggested G3BP1 as a novel MK-STYX binding partner, which was validated 
through further study (blue) (Hinton et al., 2010; Barr et al., 2013). Using the same 
technique, mass spectrometry detected heat shock protein 70 (hsp70).
Mass spec readings MK-STYX F1
G3BP1 1.3 x 10'23 3.2 x 10'3
HSP70 5.4 x 10~49 1.7 x 10‘29
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In addition to its role in SGs, G3BP1 also has been implicated to other 
cellular processes, such as neuronal differentiation. Studies have shown that 
G3BP1 deficiencies during fetal development cause lethal wide-spread neuronal 
cell death in mice (Zekri et al., 2005). Because of this G3BP1 link, an aim of this 
thesis research was to investigate whether MK-STYX had any effect on neuronal 
cells.
Thesis objectives
Although MK-STYX decreases SGs, its molecular mechanism still remains 
unclear. Studying the interaction between G3BP1 and MK-STYX provided insight 
into the role of the pseudophosphatase. Thus, clarifying the interaction between 
MK-STYX and other binding partners, such as hsp70, may provide further 
understanding of MK-STYX’s function. The goals of this thesis are to confirm 
whether another binding partner (hsp70) identified by mass spectrometry truly 
interacts with MK-STYX, and to investigate the role of MK-STYX in neuronal 
differentiation. The specific aims were as follows:
(1) To determine if MK-STYX interacts with and alters hsp70 expression
(2) To clarify MK-STYX’s mode of action in PC12 neuronal differentiation
11
Chapter 1: MK-STYX and Heat Shock Protein 70
Preliminary mass spectrometry data identified hsp70 as a potential binding 
partner of MK-STYX (unpublished data). Furthermore, hsp70 has been 
implicated in the SG lifecycle, which consists of assembly, persistence, and 
disassembly stages. This chaperone protein is capable of both blocking SG 
assembly and promoting SG disassembly, thereby reducing the number of SGs 
present in a cell (Gilks et al., 2004; Mazroui et al., 2007; Thomas et al., 2011). 
Similarly, when MK-STYX is over-expressed, cells have fewer stress granules 
(Hinton et al., 2010; Barr et al., 2013). The fact that both MK-STYX and hsp70 
are capable of decreasing SGs, and the mass spectrometry showing hsp70 as a 
possible binding partner for MK-STYX, provided a significant foundation to 
pursue this interaction further.
Chaperones and heat shock proteins
Proteins are often called the “workers of the cell”. They are responsible for 
carrying out cellular processes, from receiving extracellular signals to energy 
production. However, these workers cannot perform their functions correctly 
unless they are in the proper conformation. Within every protein, the primary 
amino acid sequence of the polypeptide contains the instructions, or blueprint, for 
proper protein folding. As a polypeptide is being synthesized, the resulting chain 
emerges from the ribosome as each amino acid is added. Yet a protein cannot 
adopt a fold until an entire domain has been synthesized. This may initially leave
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amino acids which may have hydrophobic, or “water fearing” qualities, exposed 
to the aqueous environment of the cell.
As a protein adopts its native structure, hydrophobic residues become 
buried inside the three-dimensional conformation, whereas hydrophilic, or “water 
loving”, amino acids are on the exterior of the protein and interact with water 
molecules. Without hydrophilic amino acids to shield the hydrophobic ones from 
water, hydrophobic residues tend to aggregate with other polypeptides which 
have similar characteristics. This in turn would interfere with the correct folding of 
the protein into its functional conformation. Thus, proper protein folding is 
important to carry out cellular processes, and requires mediators such as 
molecular chaperones.
Chaperone proteins aid in non-covalent folding and unfolding, and help 
improve the efficiency of protein production by helping newly formed 
polypeptides fold correctly, while also combating protein unfolding (Ellis, 2000). 
Within the larger group of molecular chaperones, there is a family of proteins 
named the heat shock proteins (hsps). The hsps are named after their molecular 
weights; for example, hsp60, hsp70 and hsp90, which have respective molecular 
weights of 60, 70 and 90 kDa. The heat shock proteins were named based on 
the fact that their protein expression increased upon cellular stress, such as an 
increase in temperature. However, there are hsps whose protein expression is 
stress-inducible, as well as hsps that are expressed under normal cellular 
conditions. These non-inducible hsps are termed heat shock cognate proteins 
(hscs).
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Heat shock protein 70 (hsp70)
The most well studied family of heat shock proteins is the hsp70 family, 
which is comprised of 11 proteins with molecular weights ranging from 66 kDa to 
78 kDa (Tavaria et al., 1996). The human hsp70s share the same domain 
architecture of an N-terminal nucleotide-binding domain and a C-terminal 
substrate-binding domain. This family of proteins is capable of binding stretches 
of exposed hydrophobic amino acids, thereby mitigating aggregation. Within 
hsp70 family, the non-inducible hsc proteins interact with newly synthesized 
proteins. In fact, roughly 30% of synthesized proteins interact with hsp70 in 
eukaryotic cells (Malyshev, 2013). Hsc proteins are also important in other 
cellular processes like protein translocation across membranes and clathrin 
uncoating (Deshaies et al., 1988; Rothman, 1989; Chappell et al., 1986). The 
major stress-inducible hsp70 (also named hsp72) mitigates protein unfolding and 
aggregation upon cellular stress. In addition, stress-inducible hsp70 antagonizes 
stress granules (SGs) by binding the prion-related domain (PRD) of TIA-1 (T- 
Cell-Restricted Intracellular Antigen-1) (Gilks et al., 2004; Anderson and 
Kedersha, 2002). This agrees with reports that increased hsp70 protein levels 
correlates with a decrease in SGs (Mazroui et al., 2007; Thomas et al., 2011).
Heat shock factor 1 (hsf-1) is a transcription factor regulating expression 
of genes encoding the stress-inducible member of the hsp70 family. This 
transcription factor is phosphorylated at twelve different sites. Some of these 
phosphorylation events enhance hsf-Ts transcriptional activity, while others 
repress it (Guettouche, 2005; Kline and Morimoto, 1997). However, the
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mechanism of transcriptional repression by phosphorylation is not clear (Kline 
and Morimoto, 1997; Knaufetal., 1996; Chuetal., 1996). Notably, the 
repressive phosphorylation event at serine 307 is carried out by the mitogen- 
activated protein kinases (MAPKs), which are dephosphorylated by the mitogen- 
activated protein kinase phosphatase (MKP) subgroup (Kline and Morimoto, 
1997; Chu et al., 1996; Mivechi and Giaccia, 1995; Dai et al., 2000).
MK-STYX and hsp70
Hsp70 was identified as a potential binding partner of MK-STYX through 
mass spectrometry experiments (Table 2) (unpublished data). However, heat 
shock proteins are often identified in large scale binding assays, as it is their 
cellular job to bind other proteins (Gingras et al., 2007). Thus, it was not clear if 
the functional significance extended beyond hsp70’s role as a chaperone. The 
reoccurrence of this reading in subsequent trials, and the smaller expectation 
value, or e-value, predicted MK-STYX as a true binding partner (unpublished 
data).
Along with hsp70, two members of the MKP subgroup, MKP-1 and 
DUSP5, show increased protein levels upon heat shock (Wong et al., 2005; 
Ishibashi et al., 1994). As previously mentioned, the MAPKs can repress the 
transcription factor hsf-1, thereby hindering hsp70 gene production. MKP-1 is 
capable of relieving this repression by dephosphorylating and inactivating 
MAPKs. As cells are stressed, there is a correlational increase in both MKP-1 
and hsp70 (hsp72) (Yaglom et al., 2003; Gabai et al., 2009). This previously
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characterized link between MKPs and hsp70 made the mass spectrometry data 
that much more intriguing, given that MK-STYX is a member of the MKP 
subgroup. Additionally, hsp70 has been implicated in human disease as it is 
over-expressed in many cancers (Zorzi and Bonvini, 2011; Leu et al., 2009; 
Murphy, 2013; Meng et al., 2011). In order to enhance understanding of hsp70 
regulation, we set-out to determine whether MK-STYX interacts with or affects 
the levels of this chaperone protein.
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Methods
Plasmids
MK-STYX was cloned in a pMT2 expression vector to introduce 
exogenous protein to cells, as previously described (Hinton et al., 2010). The 
MK-STYX sequence was tagged on either side by a Flag epitope, encoding a 
fusion protein flanked with the Flag sequence (DYKDDDDK) on both the N and C 
terminal ends. This tagging allows for easy detection of transfected MK-STYX, 
versus endogenous MK-STYX.
Additionally, an active mutant form of MK-STYX, named M K-STYXactive, or 
F1, was previously generated (Hinton et al., 2010). The F1 plasmid contains the 
substitution of F245 to a histidine residue, and S246 to cysteine, restoring the 
PTP active site signature motif and catalytic activity. This plasmid was 
constructed by a single point mutation of the pMT2-FLAG-MK-STYX-FLAG 
vector (Hinton et al., 2010). The expression vector for green fluorescent protein 
(GFP)-tagged hsp70 (pEGFP-C3-Hsp70) was obtained from Addgene (#15215)
Cell culture
A HeLa cell line (ATCC, #CCL-2) derived from human cervical epithelial 
carcinoma cells was used in these studies. Cells were maintained at 37°C with 
5% C 02 and were grown in Minimal Essential Medium (MEM) (Gibco, Invitrogen). 
All culture media was supplemented with 10% fetal bovine serum (Invitrogen).
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To stress cells, plates were heat shocked at 45°C for 30 minutes 
approximately 42 hours post-seeding. Samples which were given a post-stress 
recovery period were transferred to a 37°C incubator immediately after heat 
shock. Recovery times ranged from 30 minutes to 8 hours.
Transient transfections
Transient transfections were performed with 2 pg of DNA, and 4 pL of 
Lipofectamine 2000 (Invitrogen). The plasmids and Lipofectamine were diluted 
into Opti-MEM I Reduced Serum Medium (Invitrogen). Opti-MEM I was removed 
and replaced with MEM/FBS 5 hours post-transfection.
Cell lysis and sample collection
All samples were collected with lysis buffer (50 mM HEPES, pH 7.5, 150 
mM NaCI, 10% glycerol, 10 mM NaF, 1% Nonidet P-40 alternative, 1 mM sodium 
orthovanadate). For each 10 ml_ of lysis buffer, one ethylenediaminetetraacetic 
acid (EDTA)-free protease inhibitor cocktail tablet was used (Roche). After 
collecting lysates, sonication was performed to break cellular membranes, 
release proteins, and to shear cellular DNA. Following centrifugation at4°C and 
20,800 x g for 10 minutes, protein concentration was determined by NanoDrop 
quantification.
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Western blots
Samples were prepared with 5X sodium dodecyl sulfate (SDS) sample 
loading buffer (250 mM Tris pH 6.8, 10% SDS, 30% glycerol, 0.02% 
bromophenol blue) and dithiothreitol (DTT) (Fisher Scientific). Following three 
minutes at 100°C and 1 minute centrifugation at 17,000 x g, samples were 
loaded and resolved on 10% SDS polyacrylamide gel electrophoresis (SDS- 
PAGE) gels. A protein ladder was used to determine molecular weights of protein 
bands (BioRad, Kaleidoscope Pre-stained ladder). Proteins were transferred onto 
a polyvinyl difluoride (PVDF) membrane using semidry transfer at 14 volts for 30 
minutes in transfer buffer (48 mM Tris base, 39 mM glycine, 1.3 mM SDS, 20% 
methanol, final volume of 1 L). Membranes were then blocked in 5% milk for 40 
minutes (Carnation). Probing for (3-tubulin (1:1000, secondary anti-rabbit 1:3000, 
Thermo Scientific) served as a loading control to ensure that the same amount of 
sample was added to each well. To detect inducible hsp70, an antibody specific 
for hsp72 was used (1:1000, Enzo Life Sciences). To detect transfected MK- 
STYX, anti-Flag (1:1000) was used (Sigma). For both hsp72 and Flag secondary 
antibodies against mouse were used (1:2500, Thermo Scientific). Hsf-1 antibody 
was used in a 1:1000 ratio (Enzo Life Sciences) with secondary antibodies 
against rabbit (1:2500, Thermo Scientific). Enhanced chemiluminescence (ECL 
Prime, GE Healthcare) was used to visualize protein bands.
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Immunoprecipitation
Following lysis, a small aliquot of lysate was removed and stored for total 
protein and western blot analysis. The remaining sample was incubated on ice 
with 20 pL of IgG beads (GE) for 30 minutes. This pre-clearing removed any 
nonspecific binding of background proteins. The supernatant was then 
transferred to a new tube containing 5 pL of the appropriate antibody, and was 
put on ice for one hour. The incubated lysates were purified with 30 pL of IgG 
beads by rocking at4°C for 1-2 hours. Centrifugation (4°C, 15 minutes, 20,800 x 
g) separated the unbound proteins from the beads, and supernatant was 
aspirated. Remaining lysis buffer was used to wash the beads 3 times (1 ml_ 
washes, centrifuged at 17,000 x g fo r 1 minute at room temperature following 
aspiration). Bound proteins were eluted using 40 pL of 5X SDS-sample loading 
buffer with 2 pL DTT, and were analyzed by western blotting.
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Results
In order to determine the optimal conditions for heat shock, HeLa cells 
were exposed to an elevated temperature of 45°C for 30 minutes. Following heat 
stress, samples were given a range of recovery periods from 30 minutes to 8 
hours at 37°C. Hsp70 protein levels were highest 6 hours post-stress (Figure 3).
Following preliminary characterization of hsp70 expression upon stress, 
we next wanted to determine if MK-STYX had an effect on hsp70 protein levels. 
Cells were transiently transfected with either the empty pMT2 vector, MK-STYX, 
or the active mutant, F1. Western blot analysis was used to compare the cellular 
levels of hsp70 in cells grown under normal unstressed conditions, and those 
exposed to heat stress. Following heat shock, there was no change in hsp70 
protein levels between the empty vector control and MK-STYX transfected 
samples. Thus, we conclude that MK-STYX had no effect of hsp70 protein 
expression (Figure 4A).
Cell lysates from transfected cells were also used to investigate the effect 
of MK-STYX and the active mutant on the phosphorylation pattern of heat shock 
factor 1 (hsf-1), the transcription factor for hsp70. Phosphorylation sites in hsf-1 
can either enhance or repress transcriptional activity. To determine whether MK- 
STYX or the active mutant, F1, altered the phosphorylation pattern of hsf-1, 
western blot analysis for hsf-1 was performed. Multiple bands reflect hsf-Ts 
complex phosphorylation pattern, with the lower bands being the least 
phosphorylated and the upper bands representing hyperphosphorylated hsf-1
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(Figure 4B) (Guettouche, 2005). There was no striking change in the 
phosphorylation pattern of hsf-1 in the presence of MK-STYX or F1. This result 
was consistent with the finding that MK-STYX and F1 had no effect on altering 
hsp70 protein levels. Thus, it was not warranted to further investigate MK-STYX 
effects on hsf-1 phosphorylation at specific sites.
Flowever, the question still remained whether either MK-STYX or F1 
interacted with hsp70. Therefore, immunoprecipitation experiments were 
performed to determine whether hsp70 interacted with either MK-STYX or F1. To 
ensure that any interaction with hsp70 was present under normal cellular 
conditions, and was not due to hsp70 performing its chaperone function, cells 
and cell extracts were handled under unstressed conditions. Flowever, this posed 
a challenge, as cellular levels of hsp70 are low in the absence of stress (Figure 
5A). To remedy this, a second immunoprecipitation experiment was performed 
using a GFP-tagged hsp70 expression vector was transiently transfected into 
cells, allowing for over-expression under unstressed conditions and increasing 
the odds of capturing potential interactions. This tagging caused a molecular 
weight shift in the GFP-hsp70 versus endogenous hsp70, since GFP is roughly 
27 kDa (Figure 5B). Our results indicated that the active mutant, more so than 
MK-STYX, complexes with hsp70 (Figure 5). This result is interesting, as it 
suggests the pseudophosphatase has different binding partner specificities from 
the active mutant. If MK-STYX were solely functioning as a dominant negative, 
we would expect for both proteins to interact with hsp70 with the same intensity. 
Flowever, we observe the active mutant being a stronger hsp70 interaction
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partner than the wild type MK-STYX (Figure 5A). Taken together, these data 
support the role of MK-STYX as more than a dominant negative or substrate-trap 
for the cell.
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Discussion
Although the pseudophosphatase MK-STYX was first reported in 1998, 
only one interaction partner has been identified, G3BP1, which allowed some 
insight into the functional role of MK-STYX (Wishart and Dixon, 1998; Hinton et 
al., 2010; Barretal., 2013). However, understanding of the overall molecular 
mechanism of MK-STYX still remains unclear. Thus, identifying other binding 
partners of this pseudophosphatase is imperative.
Here, we investigated hsp70 as a potential interaction partner of MK- 
STYX. Hsp70 was detected using the same proteomics approach which 
successfully identified G3BP1. Preliminary studies indicate that hsp70 is a 
binding partner for both the active mutant and MK-STYX. The interaction 
between hsp70 and F1 appears to be stronger than seen with MK-STYX. 
However, the first immunoprecipitation experiment had low levels of hsp70 
protein (Figure 5A), while the second trial had decreased transfection efficiency 
of the MK-STYX expression plasmid (Figure 5B). The fact that hsp70 and MK- 
STYX were never equally over-expressed in the same trial could explain why 
capturing any potential interaction was more elusive. Further trials in samples 
over-expressing both proteins of interest could help validate these preliminary 
findings.
Interestingly, the immunoprecipitation results do not agree with the initial 
mass spectrometry data (Table 2), which suggested that MK-STYX would have 
greater affinity for hsp70 over F1. A potential reason for this disagreement could
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be due to a difference in cell lines used for each assay. The initial mass 
spectrometry data was performed in COS-1 cells, which are African green 
monkey fibroblast-like cells (Hinton et al., 2010). Alternatively, the 
immunoprecipitation experiments utilized the HeLa cell line, derived from human 
cervical epithelial carcinoma cells.
The fact that MK-STYX and the active mutant appear to have different and 
unique affinities for a shared substrate supports the idea that 
pseudophosphatases have specific binding partners from their active homologs. 
Furthermore, it provides evidence that pseudophosphatases, such as MK-STYX, 
function beyond a dominant negative role of protecting phosphorylated residues 
from phosphatases.
Historically, catalytically inactive enzymes were thought solely to act as 
substrate traps, or dominant negatives. These proteins would effectively protect 
target substrate from interacting with other catalytically active enzymes (Hunter, 
1998). Other catalytically inactive PTPs, or pseudophosphatases, have been 
found to have regulatory roles in cell, such as the catalytically inactive MTM 
proteins which regulate their active MTM binding partners (Laporte et al., 2003; 
Begley and Dixon, 2005). If MK-STYX were acting as a dominant negative, it 
would be predicted to have similar binding affinities as the active mutant 
phosphatase.
Additionally, we found that MK-STYX does not alter the protein levels of 
hsp70. Simultaneous experiments were performed to determine whether MK- 
STYX and F1 were altering the phosphorylation pattern of the hsp70 transcription
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factor, hsf-1. We found no apparent changes in hsf-1 phosphorylation caused by 
the presence of either MK-STYX or F1, indicating that MK-STYX and F1 were not 
altering the repressive phosphorylation of hsp70’s transcription factor. This result 
is consistent with the finding that MK-STYX did not alter hsp70 protein levels.
Although MK-STYX and hsp70 may not be strong interaction partners, it 
would be interesting to investigate their combined effect on decreasing SGs. MK- 
STYX in known to interact with G3BP1, a nucleator of SG formation. On the other 
hand, hsp70 is able to promote SG disassembly though binding the PRDs of 
proteins like TIA-1. If MK-STYX was blocking SG formation, and hsp70 was 
promoting disassembly, the combined effect of both of these proteins could 
cause a drastic decrease is SGs, which could have important therapeutic 
applications.
Many neurodegenerative disorders, such as Parkinson's and Alzheimer’s 
disease, are caused by an increase in amyloidosis, or insoluble protein 
aggregates. Hsp70 has a role in disassembling aggregates, and has been 
identified by many groups as a potential therapeutic target (Cummings et al.,
2001; Evans et al., 2010). Additionally, it has been suggested that a high 
incidence of SGs is linked to and promotes these diseases.
While stress granules are primarily composed of mRNA, some of the 
RNA-binding proteins responsible for promoting SG formation, like TDP-43 (TAR- 
DNA-binding protein) and FUS (fused in sarcoma), are also components of 
neurodegenerative protein aggregates (Li et al., 2013; Wolozin, 2012). Because 
of this association, SGs are thought to serve as initiators, or “seeds” for protein
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aggregates (Bentmann et al., 2013). Notably, both TDP-43 and FUS contain 
prion-related domains, and it is through interactions with this domain that hsp70 
disassembles SGs (Gilks et al., 2004).
By 2050, it is predicted that one person will develop Alzheimer’s disease 
every 33 seconds in the U.S. (Alzheimer’s Association, 2012). Thus, there will be a 
national crisis for development of therapeutics that will combat Alzheimer’s and 
other neurodegenerative diseases. Furthering our understanding as to how both 
MK-STYX and hsp70 decrease the presence of SGs may be insightful to drug 
development. The data presented in this chapter show MK-STYX has no effect 
on hsp70 protein expression or hsf-1 phosphorylation. However, the preliminary 
results suggesting differential binding of wild-type MK-STYX and the active 
mutant (F1) with hsp70 could be a significant finding and warrants further 
investigation. In addition, it will be interesting to determine whether MK-STYX 
and hsp70 can synergistically combat cellular aggregates which are major 
culprits of neurologic disorders.
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Figure 3: Time course of inducible hsp70 protein levels in HeLa 
cells. All samples were grown and cultured at 37°C. (A) Stressed 
samples were exposed to heat shock (45°C for 30 minutes) and had 
varied post-stress recovery times at 37°C. (B) ImageJ was used to 
normalize hsp70 protein levels to p-tubulin.
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Figure 4: Effects of MK-STYX and F1 on hsp70 protein levels and hsf-1 
phosphorylation. HeLa cells were either not stressed, or heat shocked (HS) at 
45°C for 30 minutes with a 6 hour recovery period at 37°C. P: pMT2, M: MK-STYX, 
F1: active mutant (n=3). (A) In the absence of stress, all samples had low levels of 
inducible hsp70. Following heat shock, there was no change between the empty 
vector control and experimental samples. (B) The same samples showed no 
obvious changes in the phosphorylation pattern of hsf-1 in the presence of MK- 
STYX or the active mutant, as seen in the multiple bands ranging from 80-95 kDa 
representing phosphorylation events.
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Figure 5: Heat shock protein 70 immunoprecipitation. M: MK-STYX, F1: active 
mutant, P: pMT2, H: hsp70, G: GFP. (A) Endogenous hsp70 was used to detect 
potential interactions with MK-STYX or the active mutant. HeLa cells were transfected 
with either pMT2, MK-STYX, or F1. This result agrees with panel A showing the 
active mutant as a hsp70 interaction partner; however, it also shows MK-STYX 
interacting with hsp70, but to a lesser extent. (B) HeLa cells were co-transfected with 
expression plasmids for proteins of interest (Flag-tagged MK-STYX, Flag-tagged F1, 
pMT2, hsp70, pEGFP). The top panel shows F1 interacting with hsp70. The bottom 
panel shows the presence of transfected and endogenous hsp70.
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Chapter 2: MK-STYX and Neuronal Differentiation
As neuronal cells receive signals such as neurotransmitters and 
neurotrophins, they respond with biochemical and morphological changes. This 
process can be seen in the commonly used rat PC12 cell line. In the absence of 
nerve growth factor (NGF), PC12 cells have a rounded morphology. Upon NGF 
stimulation, they undergo dramatic morphological changes with the extension of 
neuronal outgrowths, or neurites (Greene and Tischler, 1976). Additionally, these 
cells are capable of differentiating into sympathetic neurons and can form 
specialized neuronal structures, such as synapses (Fujita et al., 1989; Schubert 
et al., 1977). Previously, the Hinton lab found that over-expression of MK-STYX 
is sufficient to neurite outgrowth in PC 12 cells. Here, we show MK-STYX as a 
critical regulator of neuronal differentiation, as knocking-down MK-STYX 
expression results in a decrease in neurite outgrowth.
MK-STYX in neuronal processes
To date, the only published binding partner of MK-STYX is G3BP1, a well 
characterized marker for stress granules (Hinton etal., 2010; Barr etal., 2013; 
Tourriere et al., 2003). Identifying this binding partner led to an investigation of 
MK-STYX’s role in stress granule assembly (Hinton et al., 2010). However, 
G3BP1 has also been shown to play a role in neuronal processes. More 
specifically, mouse studies have shown that knocking-out G3BP1 lead to 
dysfunctional synaptic signaling and ataxia (Martin et al., 2013). These G3BP1
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results inspired us to explore whether MK-STYX might also be important in 
neuronal differentiation. In doing so, we have found that the pseudophosphatase 
induces neuronal outgrowths in rat pheochromocytoma PC12 cells with and 
without nerve growth factor stimulation (unpublished data, Kristen Wong). These 
neurites have not been specifically categorized as either dendrites or axons.
Extracellular signal-regulated kinases
MAPKs are kinases which target phospho-Ser and phospho-Thr residues 
and are activated by a dual phosphorylation event in their conserved T-X-Y motif 
(T: threonine, X: any amino acid, Y: tyrosine). This group is composed of the 
ERKs (extracellular signal-regulated kinases), along with the JNKs (c-Jun N- 
terminal kinases) and p38s (p38 mitogen-activated protein kinases). The ERK 
family includes ERK1 and ERK2 (commonly referred to as ERK1/2), which share 
85% of their sequences (Boulton and Cobb, 1991). Furthermore, the ERKs have 
been implicated in neuronal outgrowth; their sustained activation is critical for 
neurite extension in PC12 cells (Fukuda et al., 1995; Kao et al., 2001; Vaudry et 
al., 2002).
Epidermal growth factor (EGF) and nerve growth factor (NGF) are ligands 
which activate the small GTPase, Ras. This protein is active when it is bound to 
guanosine triphosphate (GTP), and becomes inactive when GTP is hydrolyzed to 
guanosine diphosphate (GDP). Other proteins termed GEFs (guanine nucleotide 
exchange factors) and GAPs (GTPase-activating proteins) help cycle GTPases 
between the “on” and “off’ state, respectively. Once activated, Ras initiates the
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MAPK signaling cascade which results in the dual phosphorylation and activation 
of ERK1/2 by MEKs (mitogen-activated protein kinase kinases).
Different growth factors and the duration of ERK signaling can cause two 
different outcomes in PC 12 cells. Stimulation with epidermal growth factor (EGF) 
induces transient ERK signaling, leading to cell proliferation. In contrast, 
stimulation with nerve growth factor (NGF) results in prolonged ERK signaling, 
and induces neuronal outgrowth.
As MK-STYX is a member of the mitogen-activated protein kinase 
phosphatase (MKP) subgroup, it was of interest to determine whether the 
pseudophosphatase affects ERK activity in PC12 cells. We found that MK-STYX 
induces neuronal outgrowths without NGF stimulation, and longer neurites upon 
stimulation (unpublished data, Michelle Munyikwa). MK-STYX was not inducing 
neurite outgrowth by altering Ras activity or the downstream MAPK cascade 
(unpublished data, Brittany Flowers and Kristen Wong).
Rho subfamily
The Rho family is a subgroup of Ras-related GTPases, which also switch 
between “on” and “off’ states based on their GTP or GDP binding state, 
respectively. Within this family, Rac1, Cdc42 and RhoA have been implicated in 
the regulation of neuronal differentiation.
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RhoA and cell rounding
Whereas Rac1 and Cdc42 promote neurite outgrowth through the actin 
cytoskeleton (Daniels et al., 1998; Aoki et al., 2004), RhoA causes neurite 
retraction via cytoskeletal contraction, thereby promoting cell rounding. When 
PC12 cells are stimulated with NGF, RhoA becomes phosphorylated on serine 
188, which selectively blocks the binding of its downstream effector ROCK (Rho- 
associated kinase) (Nusser et al., 2006). The serine/threonine kinase ROCK is 
the main effector which causes neurite retraction in PC12 cells. This is achieved 
through downstream signaling via increasing myosin light-chain phosphorylation 
and activating LIMK (LIM kinase 1). Both of the downstream effects promotes 
neuronal cell rounding (Meberg and Bamburg, 2000; Fujita et al., 2001).
RhoA. Ras and G3BP1
Interestingly, the GAPs for Ras and RhoA (p120 and p190 respectively) 
have been found to interact, thereby linking Ras and RhoA signaling (Ellis et al., 
1990; Settleman et al., 1992). p120 [Ras GTPase activating protein] has an N- 
terminal region composed of a SH3 domain, flanked by two SH2 domains. p190 
[Rho GTPase activating protein] becomes phosphorylated on two tyrosine 
residues which serve as docking sites for the SH2 domains of p120. This 
association facilitates the localization of p 190 to RhoA at the cell membrane, 
leading to a decrease in RhoA signaling (Bradley et al., 2006). Alternatively, the 
GAP:GAP interaction causes a decrease in p120 activity resulting in prolonged 
Ras/MAPK activation (Moran et al., 1991).
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As p120 associates with p190, its SH3 domain becomes more accessible 
for additional protein interactions (Hu and Settleman, 1997). Notably, G3BP1 is 
one of the few proteins known to bind the SH3 domain of p120 (Irvine et al., 
2004; Pamonsinlapatham et al., 2009). This interaction between G3BP1, p120, 
and p190 links MK-STYX to the Ras and RhoA signaling pathways (Figure 6).
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Figure 6: Potential pathways for MK-STYX induced neurite outgrowth. MK-
STYX induces PC12 differentiation. Both the Ras and RhoA pathways are known 
to influence this process through their respective downstream effectors, the MAPK 
cascade/ERKs and ROCK. As a MKP, MK-STYX could be acting through ERK 
signaling. However, MEK inhibitor studies show that MK-STYX acts independently 
of this MAPK. Alternatively, by decreasing RhoA activity, the pseudophosphatase 
could block cell rounding and promote neurite extension.
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MK-STYX affecting RhoA activity
Although MK-STYX is a member of the mitogen-activated protein kinase 
phosphatases (MKPs), MK-STYX induces neurite outgrowths independently of 
Ras/MAPK signaling (unpublished data, Brittany Flowers and Kristen Wong). 
Thus, we focused on the RhoA signaling cascade.
As RhoA activation antagonizes neurite outgrowth, an initial goal was to 
determine whether MK-STYX was inducing neuronal outgrowths by altering 
RhoA activity. Using a RhoA activity assay, we found a significant correlation 
between over-expressing MK-STYX and decreasing RhoA activity (unpublished 
data, Brittany Flowers).
While we have accumulated a significant amount of data on the role of 
MK-STYX in PC12 cell differentiation, experiments have relied on introducing 
and over-expressing exogenous protein. Thus, this thesis research sought to 
determine whether MK-STYX is essential for PC12 differentiation. To address 
this question, MK-STYX knockdown experiments in PC12 cells were performed
36
Methods
Cell culture
The PC12 cell line was originally isolated from a rat pheochromocytoma 
tumor. These cells were obtained from the American Type Cell Culture (ATCC) 
(Greene and Tischler, 1976). Cells were grown at 37°C with 5% CO2 in Roswell 
Park Memorial Institute (RPMI) medium supplemented with 10% horse serum 
(HS) and 5% fetal bovine serum (FBS) (Gibco, Invitrogen).
Knock-down experiments and transfection
The Hinton lab has shown that MK-STYX is endogenously expressed in 
PC12 cells (unpublished data). To reduce MK-STYX protein expression, a short 
hairpin RNA expression plasmid (shRNA-STYXL1, referred to as MK-STYX 
shRNA) (Qiagen) was transfected into PC12 cells 12 hours after seeding in 60 
mm culture dishes. Additionally, a scrambled shRNA negative control was used. 
This scrambled shRNA is nonspecific and has no gene target once introduced 
into the cell. The shRNA expression plasmids contained a green fluorescent 
protein (GFP) tag, allowing for easy discrimination between transfected and non­
transfected cells.
In order to introduce 0.4 pg of shRNA expression plasmid per sample, 0.8 
pL Lipofectamine 2000 (Invitrogen) was used. The shRNA expression plasmids 
and Lipofectamine were diluted with Opti-MEM I Reduced Serum Medium 
(Invitrogen). Opti-MEM I was removed and replaced with fresh RPMI/HS/FBS 4
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hours post-transfection. Real-time quantitative polymerase chain reaction (RT- 
qPCR) was used to ensure knock-down of MK-STYX by the MK-STYX shRNA 
construct (data not shown). Cells were stimulated with 100 ng/mL of nerve 
growth factor (NFG) 24 hours after the shRNAs were introduced
Cell imaging
Live cell images were taken over the course of a week using an inverted 
fluorescence microscope (Nikon). Neurite outgrowth (> 20 pm) was measured 
with NIS-Elements Basic Research software (version 3.10, Nikon). Figures were 
formatted using Adobe Illustrator software.
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Results
Over the course of seven days, NGF-stimulated PC12 containing either 
the scrambled shRNA or MK-STYX shRNA expression plasmids were assayed 
for neurite outgrowth. By day 2, cells containing scrambled shRNA exhibited 
neurite formation (> 20 pm) (Figure 7). In contrast, PC 12 cells transfected with 
MK-STYX shRNA did not form neurites until day 3, and neurites that 
subsequently formed were shorter than those in the negative control cells (Figure 
8).
Because neither sample showed neurite outgrowth until day 2, cells were 
scored for neurite outgrowth on day 3. This way, we were able to capture the 
initial stages of neurite growth. Additionally, as PC12 cells are grown for 
extended periods of time, the cells clump together (Greene and Tischler, 1976). 
By scoring on day 3, we were able to visualize individual cells, allowing for more 
precise scoring. The resulting data showed that the MK-STYX shRNA decreased 
the percentage of neurite outgrowth when compared to the scrambled shRNA 
negative control (Figure 9).
In the future, it would be interesting to assay MK-STYX protein expression 
along the 7 day course using western blot analysis. If the MK-STYX shRNA 
expression vector was not consistently expressed throughout the 7 days, it could 
potentially correlate to the formation and elongation of neurites in knock-down 
samples.
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Discussion
In order to learn about the functional role of MK-STYX, potential binding 
partners were identified using a proteomics approach. Through this method, 
G3BP1 was identified as the first interaction partner of this pseudophosphatase 
(Hinton etal., 2010). Because of G3BP1’s role in neuronal development, we 
were curious whether MK-STYX would have a role in this process, and focused 
our attention on MK-STYX and neuronal processes. Here, we show MK-STYX is 
an important regulator of PC12 differentiation that is capable of inducing neurite 
outgrowth. Furthermore, MK-STYX knockdown data suggest that MK-STYX is 
important for PC12 neuronal differentiation.
Two of the important signaling pathways that regulate neuronal 
differentiation are controlled by the small GTPases, Ras and RhoA. The 
Ras/MAPK pathways causes neurite outgrowth, while the RhoA pathway 
promotes cell rounding. Activity assays showed MK-STYX was not altering 
Ras/MAPK signaling, but was decreasing RhoA activity (unpublished data, 
Brittany Flowers). Now that MK-STYX is known to influence RhoA activity, it will 
be interesting to determine how this pseudophosphatase affects downstream 
effectors of this GTPase.
Parkinson’s disease is a neurodegenerative disorder characterized by the 
loss of dopamine-producing cells. As an important neurotransmitter, the loss of 
dopamine impairs proper motor movement and muscle control (National 
Parkinson Foundation, 2013). Interestingly, when PC12 are stimulated with NGF,
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the cells are capable of releasing large amounts of dopamine (Lim et al., 1995; 
Amino et al., 2002). Because of this, PC12 grafts have been investigated in 
various hosts, such as guinea pigs, and primates. In all of these studies, PC12 
grafts have proven to be an effective dopamine delivery method, lasting for up to 
1 year (Ono et al., 1997; Date et al., 2000; Yoshida et al., 1999). MK-STYX is an 
important regulator of neuronal differentiation in PC12 cells, and could potentially 
promote dopamine release in grafted PC12 cells. Learning more about how MK- 
STYX induces differentiation could potentially point to enhancing therapeutic 
applications for Parkinson’s disease.
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Figure 7: Neuronal outgrowth in PC12 cells containing scrambled shRNA.
Cells were transfected GFP-tagged scrambled shRNA, and stimulated with NGF 
24 hours later. Neurite length (|jm) was then measured over a 7 day course.
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Figure 8: shRNA knock-down of MK-STYX reduces neurite outgrowth in 
PC12 cells. Cells were transfected with a GFP-tagged MK-STYX shRNA 
expression plasmid. Following NGF stimulation, neurite length (pm) was 
measured over 7 days.
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Scrambled shRNA MK-STYX shRNA
Figure 9: shRNA knock-down of MK-STYX significantly decreases number of 
PC12 cells with neurite outgrowth. shRNA expression plasmids were transiently 
transfected into cells. The scrambled shRNA served as a negative control for the 
experimental MK-STYX shRNA. From each sample, 100 cells were scored for 
neurite outgrowth (> 20 pm) 3 days after NGF stimulation (100 ng/mL). Roughly 
80% of scrambled shRNA-transfected cells had neurite formation, while cells 
containing the MK-STYX shRNA showed only ~25% of cells having neurites (n=3).
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